Lesotho vs Philippines: Expected chances of death from non-communicable diseases, by gender
Lesotho
40.0%
in 2021
Philippines
38.7%
in 2021
Lesotho rank
6th
Philippines rank
7th
Expected chances of death from non-communicable diseases, by gender over time
- Lesotho
- Philippines
How they compare
Lesotho currently reports 40.0% against 38.7% in Philippines, a difference of 1.3%.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Lesotho ahead.
Lesotho ranks 6th and Philippines ranks 7th of 185 countries.
Lesotho has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lesotho | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.7% | 30.7% | 0.0% | Lesotho |
| 2010s | 39.0% | 32.5% | 6.6% | Lesotho |
| 2020s | 41.4% | 35.4% | 6.0% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected chances of death from non-communicable diseases, by gender, Lesotho or Philippines?
- Lesotho, at 40.0% against 38.7% in Philippines as of 2021.
- What is the difference in expected chances of death from non-communicable diseases, by gender between Lesotho and Philippines?
- 1.3%, with Lesotho ahead.
- How many years of comparable data are there for Lesotho and Philippines?
- 22 years are reported by both, from 2000 to 2021.
- How do Lesotho and Philippines rank globally for expected chances of death from non-communicable diseases, by gender?
- Lesotho ranks 6th and Philippines ranks 7th of 185 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Expected chances of death from non-communicable diseases, by gender. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.